Compound information
- Natural Products
- ZC2073944
- Molecular Formula
- C10H9ClF3NOS
- Molecular Weight
- 283.004547248 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-chloro-N-[4-(trifluoromethylsulfanyl)phenyl]propanamide
- InChI
- InChI=1S/C10H9ClF3NOS/c1-6(11)9(16)15-7-2-4-8(5-3-7)17-10(12,13)14/h2-6H,1H3,(H,15,16)/t6-/m0/s1
- InChI Key
- WSAZPHMMLRGLDR-LURJTMIESA-N
- SMILES
- C[C@H](Cl)C(=O)Nc1ccc(SC(F)(F)F)cc1
- Source
- ZINC000004290634
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 17 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 29.1 Å2 | LogP | 4.001 |
LogS | -3.56 | LogD | 3.531 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.074 | Pgp substrate | 0.002 |
HIA | 0.963 | F20 % | 0.991 |
F30 % | 0.974 | Caco-2 | -4.641 |
MDCK | -4.692 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.484 | PPB | 77.86 |
VD | 2.769 | Fu | 1.244 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.999 | CYP1A2 substrate | 0.618 |
CYP2A6 substrate | 0.877 | CYP2B6 substrate | 0.703 |
CYP2C19 inhibitor | 0.682 | CYP2C19 substrate | 0.971 |
CYP2C8 substrate | 0.796 | CYP2C9 inhibitor | 0.514 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.006 |
CYP2D6 substrate | 0.898 | CYP2E1 substrate | 0.901 |
CYP3A4 inhibitor | 0.023 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.198 | CL | 11.546 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.421 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.668 | Rat Oral Acute Toxicity | 0.135 |
FDAMDD | 0.157 | Skin Sensitization | 0.003 |
Carcinogenicity | 0.034 | Eye Corrosion | 0.542 |
Eye Irritation | 0.434 | Respiratory Toxicity | 0.939 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.529 | IGC50 | 3.624 |
LC50FM | 5.533 | LC50DM | 7.254 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.291 | NR-AR-LBD | 0.267 |
NR-AhR | 0.478 | NR-Aromatase | 0.159 |
NR-ER | 0.383 | NR-ER-LBD | 0.514 |
NR-PPAR-gamma | 0.628 | SR-ARE | 0.098 |
SR-ATAD5 | 0.481 | SR-HSE | 0.286 |
SR-MMP | 0.26 | SR-p53 | 0.835 |
Similar covalent drugs
No similar covalent drugs found for this compound.